|
Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 310.48 DKK | +0.19% |
|
+1.19% | -4.58% |
| 17.02. | Novo Holdings löst Aktienbeteiligung an Recursion Pharmaceuticals auf | RE |
| 17.02. | Die große KI-Neubewertung |
Hauptkonkurrenten
| KGV (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | Marktkap. / EBITDA (N) | Marktkap. / EBIT (N) | Dividendenrendite (N) | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 14.77x | 6.35x | -1.66x | 5.12x | 10.74x | 12.52x | 3.51% | 218 Mrd. | ||
| 31.01x | 18.94x | 0.68x | 11.75x | 23.61x | 24.75x | 0.64% | 926 Mrd. | ||
| 24.77x | 6.7x | -2.26x | 6.01x | 16.36x | 18.06x | 2.18% | 586 Mrd. | ||
| 65.02x | 22304.6x | 1.3x | 7.68x | 19.02x | 19.58x | 2.81% | 412 Mrd. | ||
| 19.35x | 6.82x | 1.02x | 4.81x | 11.94x | 13.37x | 2.72% | 382 Mrd. | ||
| 33.11x | 7.3x | 0.81x | 5.93x | 17.67x | 18.47x | 1.55% | 326 Mrd. | ||
| 21.99x | 6.72x | 4.51x | 6.1x | 15x | 16.01x | 2.65% | 317 Mrd. | ||
| 15.7x | 5.48x | 1.05x | 5.03x | 10.98x | 12.2x | 2.66% | 302 Mrd. | ||
| 25.23x | 16.68x | 6.3x | 6.36x | 11.23x | 14.43x | 2.69% | 201 Mrd. | ||
| 22.77x | 8.55x | 0.01x | 7.04x | 12.87x | 15.55x | 2.14% | 193 Mrd. | ||
| 13.35x | 1.72x | 0.29x | 3.22x | 7.97x | 9.39x | 6.25% | 156 Mrd. | ||
| 26.91x | 5.12x | 1.71x | 8.27x | 18.38x | 19.17x | -.--% | 121 Mrd. | ||
| 12.31x | 5.08x | 0.3x | 3.18x | 8.86x | 9.24x | 4.18% | 123 Mrd. | ||
| 16.12x | 6.25x | 0.13x | 3.2x | 9.25x | 10.78x | 2.89% | 122 Mrd. | ||
| 11.64x | 1.22x | 0.25x | 2.45x | 8x | 8.82x | 5.26% | 112 Mrd. | ||
| 35.26x | 7.62x | 3.36x | 11.38x | 22.37x | 23.85x | 2.76% | 98.24 Mrd. | ||
| 50.25x | 1.27x | 0.81x | 2.83x | 10.45x | 29.93x | 3.6% | 57.14 Mrd. | ||
| 44.26x | 6.32x | 1.4x | 10.57x | 35.37x | 36.84x | 0.45% | 56 Mrd. | ||
| 152.31x | 1.48x | -1.35x | 1.76x | 8.44x | 14.56x | 0.23% | 57.3 Mrd. | ||
| 23.21x | 2.21x | 1.9x | 3.97x | 15.71x | 17.57x | 1.73% | 49.27 Mrd. | ||
| Durchschnitt | 32.97x | 1’121.32x | 1.03x | 5.83x | 14.71x | 17.25x | 2.54% | 240.64 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | 29.37x | 1’915.70x | 0.82x | 6.91x | 16.07x | 17.68x | 2.28% |
- Börse
- Aktien
- A3EU6F Aktie
- Sektor Novo Nordisk A/S
- Sektorale Bewertungen
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben
















